Similar articles

• Choice of rating form for evaluating anxiolytics.

  Wang RI, Kochar C. Wang RI, et al. Psychopharmacol Bull. 1989;25(2):291-5. Psychopharmacol Bull. 1989. PMID: 2574898
• A comparative study of alpidem, a nonbenzodiazepine, and lorazepam in patients with nonpsychotic anxiety.

  Diamond BI, Nguyen H, O'Neal E, Ochs R, Kaffeman M, Borison RL. Diamond BI, et al. Psychopharmacol Bull. 1991;27(1):67-71. Psychopharmacol Bull. 1991. PMID: 1677774 Clinical Trial.
• Comparison of RDC, DSM-III, DSM-III-R diagnostic criteria for generalized anxiety disorder.

  Wolk SI, Horwath E, Goldstein RB, Wickramaratne P, Weissman MM. Wolk SI, et al. Anxiety. 1996;2(2):71-9. doi: 10.1002/(SICI)1522-7154(1996)2:2<71::AID-ANXI2>3.0.CO;2-G. Anxiety. 1996. PMID: 9160604
• [Treatment of generalized anxiety: new pharmacologic approaches].

  Boulenger JP. Boulenger JP. Encephale. 1995 Nov-Dec;21(6):459-66. Encephale. 1995. PMID: 8674471 Review. French.
• [Phytopharmacy-- traditional empiricism or pharmacological evidence? Part 1: Generalized anxiety and anxiolytics].

  Bastigkeit M. Bastigkeit M. Med Monatsschr Pharm. 2014 Sep;37(9):316-22. Med Monatsschr Pharm. 2014. PMID: 25282745 Review. German. No abstract available.